Biotechnology

Inceptor Bio raises $37m from Series A to advance CAR-T lead programme

Biotechnology firm Inceptor Bio has raised $37m from Series A funding round that was led by Kineticos Ventures.

Arbor Biotechnologies raises $215m through Series B round

Massachusetts-based Arbor Biotechnologies has raised $215m through Series B financing round, and plans to use the proceeds to advance its next-generation precision editing therapeutics.

Prime Medicine launches with $315m funding to advance Prime Editing platform

Biotechnology company Prime Medicine has launched with $315m funding to advance its Prime Editing platform, a next-generation gene editing technology.

NIAID grants $2.5m to 12 institutes for bacteriophage therapy research

A branch of the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) has granted $2.5m to 12 institutes across the world for bacteriophage therapy research.

Akron Biotech to exclusively manufacture Human AB Serum for Octapharma

Akron Biotechnology (Akron Biotech) has signed an exclusive global agreement with Swiss-based Octapharma, to manufacture virally inactivated Human AB Serum for the cell therapy market.

Cure Genetics, Boehringer to develop AAV vectors for gene therapy

Chinese biotechnology firm Cure Genetics has partnered with Boehringer Ingelheim for the development of novel Adeno-Associated Virus (AAV) vectors to be used in gene therapies.